Therefore, the correlation of FOXA1 expression with luminal A tumours[45] could explain lower expression of TOX3 in our study and poorer survival of carriers of the rs3803662 risk allele and luminal A tumours. The gene discussed is FOXA1; the disease is neoplasm.